1163567007: Belumosudil mesilate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\Protein-tyrosine kinase inhibitor\Rho-associated protein kinase inhibitor\Belumosudil mesilate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Heterocyclic compound\Belumosudil mesilate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

4597372013 Belumosudil mesilate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4597373015 Belumosudil mesilate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

4597374014 Belumosudil mesylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Belumosudil mesilate	Is a	Heterocyclic compound	true	Inferred relationship	Some
Belumosudil mesilate	Is a	Rho-associated protein kinase inhibitor	true	Inferred relationship	Some
Belumosudil mesilate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Rho-associated protein kinase inhibitor	true	Inferred relationship	Some
Belumosudil mesilate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Belumosudil (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely belumosudil (as belumosudil mesilate) 200 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Belumosudil mesilate	Inferred relationship	Some	1

This concept is not in any reference sets